Trabectome - Glaucoma Treatment
Glaucoma, the second leading cause of blindness and affects more than four million Americans. Franciscan Healthcare - Munster was the first hospital in Indiana to purchase a minimally invasive glaucoma treatment called Trabectome.
Trabectome is an FDA-cleared device that removes glaucoma-causing tissue, improves natural drainage pathways of the eye and eliminates pressure safely without the aid of mechanical implants or shunts. The surgery is performed through a small incision and does not leave a permanent hole or pocket in the eye wall, allowing patients to return home the same day. The Trabectome procedure, taking approximately 20 minutes, maintains a remarkably high success rate in reducing intraocular pressure (IOP) with minimum side effects.
Benefits of Trabectome
- Restoration of the eye's natural fluid balance
- Low patient risk
- Simpler than traditional therapies
- Low complication rate
- Easily combines with cataract extraction
- Safe, economical and effective